Pharmacokinetics of fluconazole in the cerebrospinal fluid of children with hydrocephalus

Chemotherapy

Volumn 51, Issue 6, 2005, Pages 370-376

  Bafeltowska, J J ^a   Buszman, E ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Cerebrospinal fluid; Fluconazole; Hydrocephalus; Pharmacokinetics

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

ADULT; ARTICLE; BRAIN VENTRICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG ELIMINATION; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROCEPHALUS; INFANT; MALE; NEUROTOXICITY; PEDIATRICS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SAMPLING; SOLID PHASE EXTRACTION; STEADY STATE; TIME;

ADOLESCENT; ANTIFUNGAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; ENCEPHALITIS; FLUCONAZOLE; HUMANS; HYDROCEPHALUS; INFANT; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; MALE; SENSITIVITY AND SPECIFICITY; VENTRICULOPERITONEAL SHUNT;

EID: 27544502957     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088965     Document Type: Article

References (21)

1. Bayston R: Hydrocephalus shunt infections. J Antimicrob Chemother 1994; 34(suppl A):75-84.
2. Dallacasa P, Dappozzo A, Galassi E, Sandri F, Cocchi G, Masi M: Cerebrospinal fluid shunt infections in infants. Childs Nerv Syst 1995;11:643-649.
3. Bafeltowska JJ, Buszman E, Mandat KM, Hawranek JK: Therapeutic vancomycin monitoring in children with hydrocephalus during treatment of shunt infections. Surg Neurol 2004;62:142-150.
4. Luer MS, Hatton J: Vancomycin administration into the cerebrospinal fluid: A review. Ann Pharmacother 1993;27:912-921.
5. Nau R, Sörgel F, Prange HW: Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections. Clin Pharmacokinet 1998;35:223-246.
6. Nau R, Kinzig-Schippers M, Sörgel F, Schinschke S, Rössing R, Müller C, Kolenda H, Prange HW: Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients. Antimicrob Agents Chemother 1997;41:987-991.
7. Nau R, Lassek C, Kinzig-Schippers M, Thiel A, Prange HW, Sörgel F: Disposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomy. Antimicrob Agents Chemother 1998;42:2012-2016.
8. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG: Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001;345:1660-1666.
9. Saxen H, Hoppu K, Pohjavuori M: Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life. Clin Pharmacol Ther 1993;54:269-277.
10. Inagaki K, Takagi J, Lor E, Okamoto MP, Gill MA: Determination of fluconazole in human serum by solid-phase extraction and reversed-phase high-performance liquid chromatography. Ther Drug Monitor 1992;14:306-311.
11. Terrel CL: Antifungal agents. II. The azoles. Mayo Clin Proc 1999;74:78-100.
12. Kim EJ, Lee HS, Zee OP, Lee ST: Sensitive and simplified HPLC analysis for the determination of fluconazole in human plasma. Arch Pharmacol Res 1998;11:250-252.
13. Bafeltowska JJ, Buszman E, Mandat K, Hawranek J: Determination of cefotaxime and desacetylce-fotaxime in cerebrospinal fluid by solid-phase extraction and high-performance liquid chromatography. J Chromatogr A 2002;976:249-254.
14. Atkinson AJ Jr: Clinical pharmacokinetics; in Daniels CD, Dedrick RL, Grudzinskas CV, Markey SP (eds): Principles of Clinical Pharmacology. San Diego, Academic Press, 2001, pp 9-20.
15. Bafeltowska J, Buszman E: Analysis of piperacillin in cerebrospinal fluid using solid-phase extraction and high-performance liquid chromatography. Ann Pol Chem Soc 2003;2:257-259.
16. Scholz H, Hofmann T, Noack R, Edwards DJ, Stoeckel K: Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children. Chemotherapy 1998;44:142-147.
17. Nau R, Prange HW: Estimation of steady state antibiotic concentration in cerebrospinal fluid from single-dose kinetics. Eur J Clin Pharmacol 1996;49:407-409.
18. Sáez-Llorens X, Castano E, García R, Báez C, Pérez M, Tejeira F, McCracken GH Jr: Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children. Antimicrob Agents Chemother 1995;39:937-940.
19. Tucker RM, Galgiani JN, Denning DW, Hanson LH, Graybill JR, Sharkey K, Eckman MR, Salemi C, Libke R, Klein RA, et al: Treatment of coccidioidal meningitis with fluconazole. Rev Infect Dis 1990;12(suppl 3):S380-S389.
20. Tucker RM, Wiliams PL, Arathoon EG, Levine BE, Harstein AI, Hanson LH, Stevens DA: Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis. Antimicrob Agents Chemother 1988;32:369-373.
21. Chin T, Fong IW, Vandenbroucke A: Pharmacokinetics of fluconazole in serum and cerebrospinal fluid in a patient with AIDS and cryptococcal meningitis. Pharmacotherapy 1990;10:305-307.